New Wave Subsidiary, Way Of Will Announces Completion of Facility Expansion
(firmenpresse) - TORONTO, FEBRUARY 18, 2021 NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR, FWB: 0XM2, OTCPK: TRMNF) an investment issuer that provides capital and support services, is pleased to announce that the expansion of Way of Wills Toronto, ON facility in anticipation of exponential sales growth is now complete.
Way of Will Inc., a fast-growing health and wellness company based in Toronto, Canada, has just completed the expansion of its production facility from 8,000 sq ft to 20,000 sq ft. In addition to the extra space, the facility upgrades also included the installation of additional manufacturing equipment as well as a designated packing area. With the added space and equipment, Way of Will is able to improve workflow and production capacity to meet the growing demands for their products while increasing profit margins at the same time.
Approximately 95% of Way of Wills products are developed and manufactured in its Toronto facility, which is then distributed to wholesalers and retail companies across Canada and the U.S. The company has seen steady positive sales growth of 30% or higher over the past few years, and is forecasting a 200-300% sales growth in light of its recent merge with New Wave Holdings Corp. The facility expansion will accommodate the anticipated increase in production demands as Way of Will continues to increase its brand in both the Canadian and U.S. markets.
This recent expansion has been a part of our business growth plan for the past year, said Willie Tsang, CEO and founder of Way of Will. Weve got a lot of exciting things in the works and our upgraded facility will help ensure that our operation continues to run smoothly while we continue to grow and evolve.
ABOUT NEW WAVE HOLDINGS CORP.
New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTCPK: TRMNF) is an investment issuer focused on the burgeoning nutraceutical and psychedelic sector and support for adaptive and progressive health and wellness products and therapies. New Wave subsidiaries contain various health and beauty products within its portfolio of non-psychoactive plants and fungi as it continues to expand its product distribution through vertical integration to provide end to end solutions while capturing a high margin business model.
Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
Daniel Fox
Chief Executive Officer
New Wave Holdings Corp.
dan(at)newwavecorp.com
Information relating to WAY OF WILL INC., contained in this news release was provided by WAY OF WILL INC. and/or its agent and has not been independently verified by the Company. The Company does not take responsibility for the accuracy of such information.
The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
FORWARD-LOOKING INFORMATION DISCLAIMER
Certain statements contained in this news release may constitute forwardlooking information, including but not limited to, applicable regulatory approval in connection with the Acquisition, the closing of the Acquisition, expansion of operations, size and quality of future tournaments and projections regarding attendance at future events. Forwardlooking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forwardlooking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forwardlooking information. The Company''s actual results could differ materially from those anticipated in this forwardlooking information as a result of competitive factors and competition for investment opportunities, challenges relating to operations in international markets, transaction execution risk, changes to the Company''s strategic growth plans, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forwardlooking information are reasonable based on current expectations and potential investment pipeline, but no assurance can be given that these expectations will prove to be correct and such forwardlooking information should not be unduly relied upon. Any forwardlooking information contained in this news release represents the Company''s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forwardlooking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="WPD and CNS Pharmaceuticals Announce Positive Opinion of the Polish Central Ethics Committee for the WPD-201 Study and Central IRB Study Level Approval for the CNS-201 Study">
" alt="Great Atlantic’s Newly Discovered Gold Bearing Outcrop with Float, Sampled over 30 Meters ">
Datum: 18.02.2021 - 09:32 Uhr
Sprache: Deutsch
News-ID 1564852
Anzahl Zeichen: 10555
contact information:
Contact person:
Town:
Wien
Phone:
Kategorie:
Business News
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 286 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"New Wave Subsidiary, Way Of Will Announces Completion of Facility Expansion
"
steht unter der journalistisch-redaktionellen Verantwortung von
New Wave Holdings Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
